SMS Pharmaceuticals Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -

385.10 -2.85 (-0.73%)Updated : 22 Jul 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	755.51	678.08	624.15	499.60
Other Net	8.35	-0.68	-0.22	-0.75
Diluted Weighted Average Shares	9.15	8.47	8.47	8.47
Depreciation/ Amortization	39.92	34.34	31.52	32.13
Operating Income	131.36	104.67	85.11	22.45
Net Income	101.99	69.14	49.83	-7.06
Income Availableto Com Excl Extra Ord	101.99	69.14	49.83	-7.06
Other Operating Expenses Total	43.59	-	-	-
Net Income Before Taxes	116.64	92.34	66.11	5.35
Minority Interest	0.00	0.00	-	-
Net Income After Taxes	88.00	67.40	49.20	3.88
Income Availableto Com Incl Extra Ord	101.99	69.14	49.83	-7.06
Costof Revenue Total	584.05	504.24	480.71	379.78
Gross Profit	302.83	278.51	228.56	142.27
Interest Inc( Exp) Net- Non- Op Total	-23.08	-11.67	-18.82	-16.28
Diluted Net Income	101.99	69.14	49.83	-7.06
DPS- Common Stock Primary Issue	0.40	0.40	0.40	0.30
Provisionfor Income Taxes	28.64	24.94	16.91	1.47
Equity In Affiliates	13.99	1.74	0.63	-10.94
period Type	-	-	-	-
Net Income Before Extra Items	101.99	69.14	49.83	-7.06
Total Revenue	886.87	782.75	709.26	522.05
period Length	12.00	12.00	12.00	12.00
Revenue	886.87	782.75	709.26	522.05
Selling/ General/ Admin Expenses Total	87.96	139.50	111.93	87.69
Diluted Normalized EPS	11.15	8.16	5.88	-0.83
Diluted EPS Excluding Extra Ord Items	11.15	8.16	5.89	-0.83
Gain( Loss)on Saleof Assets	-	0.02	0.04	-0.07

*All figures in crores except per share values

Trending Stocks

4,715.00+26.95(0.57%)

287.00+0.30(0.10%)

1,025.50-18.75 (-1.80%)

1,238.65-19.20 (-1.53%)

Related News